Everolimus-Facilitated Reduction Of Tacrolimus Provides Comparable Efficacy And Superior Renal Function Versus Standard Tacrolimus In De Novo Liver Transplant Recipients: 24-Month Results Of A Randomized Trial

被引：0
|
作者：
Saliba, Faouzi [1 ]
De Simone, Paolo [2 ]
Nevens, Frederik [3 ]
De Carlis, Luciano [4 ]
Metselaar, Herold [5 ]
Beckebaum, Susanne [6 ]
Jonas, Sven [7 ]
Sudan, Debra [8 ]
Fischer, Lutz [9 ]
Fung, John J. [10 ]
Dong, Gaohong [11 ]
Lopez, Patricia M. [12 ]
Junge, Guido [12 ]
机构：
[1] Hop Paul Brousse, Villejuif, France
[2] Azienda Osped Univ Pisana, Pisa, Italy
[3] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Louvain, Belgium
[4] Osped Niguarda Ca Granda, Milan, Italy
[5] Univ Rotterdam Hosp, Erasmus MC, Rotterdam, Netherlands
[6] Univ Hosp Essen, Essen, Germany
[7] Univ Med Ctr Leipzig, Leipzig, Germany
[8] Duke Univ, Med Ctr, Durham, NC USA
[9] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[10] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[11] Novartis Pharmaceut, E Hanover, NJ USA
[12] Novartis Pharma AG, Basel, Switzerland
来源：
HEPATOLOGY | 2012年 / 56卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LB5
引用
收藏
页码：1519 / 1519
页数：1
相关论文
共 50 条
  • [41] Everolimus and Very Low Exposure of Tacrolimus Provides Good Efficacy in De Novo Renal Transplant Recipients (RTxR) at 12 Months.
    Christiaans, M.
    Langer, R.
    Vitko, S.
    Hene, R.
    Tedesco, H.
    Cassuto, E.
    Rostaing, L.
    Asztalos, L.
    Wiecek, A.
    Henriques, A. C.
    Pascual, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 151 - 151
  • [42] EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IMPROVES KIDNEY FUNCTION VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
    Braun, F.
    Nashan, B.
    Pascher, A.
    Klein, C. G.
    Schemmer, P.
    Neumann, U.
    Kroeger, I.
    Wimmer, P.
    Schlitt, H. J.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 24 - 24
  • [43] Everolimus with Early Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients-12 Month Efficacy and Safety Results from H2304 Study
    Fung, J.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Koneru, B.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 28 - 28
  • [44] SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
    Schlitt, H. J.
    Nashan, B.
    Schemmer, P.
    Pascher, A.
    Klein, C. G.
    Neumann, U.
    Kroeger, I.
    Wimmer, P.
    Braun, F.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 25 - 25
  • [45] HEPHAISTOS study: Early use of everolimus plus reduced tacrolimus in de novo liver transplant recipients achieves high efficacy and safety compared to standard tacrolimus.
    Schemmer, P.
    Nashan, B.
    Braun, F.
    Pascher, A.
    Klein, C. -G
    Neumann, U.
    Kroeger, I
    Wimmer, P.
    Schlitt, H. J.
    TRANSPLANTATION, 2019, 103 (08) : 298 - 298
  • [46] Design of a Randomized Study Aimed To Evaluate the Efficacy and Safety of Everolimus with Reduced Exposure Tacrolimus Versus Standard Tacrolimus in Living Donor Liver Transplant Recipients.
    Song, G. W.
    Chen, C. L.
    Lee, W. C.
    Joh, J. W.
    Levy, G.
    Pomfret, E.
    Lopez, P. M.
    Guido, J.
    Hexham, J. M.
    Uemoto, S.
    Suh, K. S.
    LIVER TRANSPLANTATION, 2013, 19 : S155 - S155
  • [47] COMPARING RENAL FUNCTION IN LT RECIPIENTS WITH LOW-DOSE TACROLIMUS AND SIROLIMUS VERSUS NORMAL-DOSE TACROLIMUS, A MULTICENTER RCT; 24-MONTH RESULTS
    Mulder, Midas
    Murad, Sarwa Darwish
    de Jong, Koert
    van den Berg, Aad A. P.
    van Hoek, Bart
    Alwayn, Ian
    Erler, Nicole
    Polak, Wojciech
    de Winter, Brenda
    den Hoed, Caroline
    Metselaar, Herold
    TRANSPLANT INTERNATIONAL, 2021, 34 : 170 - 170
  • [48] Renal Function Outcomes with Everolimus Plus Reduced-Exposure Tacrolimus in de Novo Living Donor Liver Transplantation: 24-month results from the H2307 study
    Suh, Kyung Suk
    Jeng, Long-Bin
    Soin, Arvinder Singh
    Lee, Wei-Chen
    Lee, Sung Gyu
    Grant, David
    Yoshizumi, Tomoharu
    El Meteini, Mahmoud
    Meier, Matthias
    Kochuparampil, Jossy
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary
    TRANSPLANTATION, 2018, 102 : S21 - S22
  • [49] IMPACT ON RENAL FUNCTION OF STEPWISE WITHDRAWAL OF TACROLIMUS COMBINED WITH EVEROLIMUS AND EC-MPS VS STANDARD TREATMENT COMBINING TACROLIMUS AND EC-MPS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS OF THE SIMCER STUDY
    Conti, F.
    Saliba, F.
    Duvoux, C.
    Dharancy, S.
    Dumortier, J.
    Di Giambattista, F.
    Calmus, Y.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S152 - S153
  • [50] IMPACT ON RENAL FUNCTION OF STEPWISE WITHDRAWAL OF TACROLIMUS COMBINED WITH EVEROLIMUS AND EC-MPS VS STANDARD TREATMENT COMBINING TACROLIMUS AND EC-MPS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS OF THE SIMCER STUDY
    Saliba, F.
    Duvoux, C.
    Dharancy, S.
    Dumortier, J.
    Calmus, Y.
    Di Giambattista, F.
    Conti, F.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 7 - 8
12345